Free Webinar

Overcoming Challenges in Survival Analysis Trial Design

Overcoming Challenges in Survival Analysis Trial DesignIn this webinar, you will learn about:

  • Challenges you encounter in survival analysis trial design
  • How non-proportional hazards impacts your power and analysis
  • Logistical and statistical issues for survival adaptive designs
  • nQuery Practical Demonstrations
    • Log-Rank Test
    • Linear-Rank Tests/MaxCombo
    • Group Sequential Log-Rank Test

Duration - 60 minutes

Speaker: Ronan Fitzpatrick, Lead Statistician, Statsols

Can't make the date?

Everyone who registers will receive a video recording, slides and example files.

Register Now

More about this webinar

Complex Survival Patterns and Impact of Adaptive Design

Survival analysis is one of the most common areas of interest in clinical trials, especially for oncology trials. However, survival analysis is also one of the more complex areas for statistical analysis.

For clinical trial design, this can require complex assumptions regarding accrual, survival and censoring patterns, especially as newer therapeutics such as immunotherapies challenge traditional statistical approaches. In addition, the wider adoption of adaptive designs poses unique challenges in the survival analysis context that require particular attention.

The emergence of newer therapeutic approaches (such as immunotherapies) with more complex survival effects has led to a re-evaluation of the traditional approaches to statistical analysis of survival endpoints. Non-proportional hazard patterns such as delayed effects have spurred interest in methods such as linear-rank tests, MaxCombo procedures and restricted mean survival time (RMST) to allow more accurate inference for these more complex survival scenarios.

In addition, the wider adoption of adaptive designs poses unique challenges for survival analysis trials where practical aspects such as interim timing are far more challenging while issues such as potential bias due to the chosen adaptation strategy or the impact of non-proportional hazards on adaptive design assumptions require careful evaluation.

In this webinar, we provide an overview of the challenges encountered when designing survival analysis clinical trials, look at the recent interest in the effect of non-proportional hazards and explore the specific issues faced when applying adaptive designs in the survival analysis context.


About nQuery

nQuery helps make your clinical trials faster, less costly and more successful. It is an end-to-end platform covering Frequentist, Bayesian, and Adaptive designs with 1000+ sample size procedures.

nQuery Solutions

Sample Size & Power Calculations
Calculate for a variety of frequentist and Bayesian designs

Adaptive Design
Design and analyze a wide range of adaptive designs

Milestone Prediction
Predict interim analysis timing or study length

Randomization Lists
Generate and save lists for your trial design

Details

Thur, Sept 24th, 2026
9-10am Pacific

Who is this for?

This will be highly beneficial if you're a biostatistician, scientist, or clinical trial professional that is involved in sample size calculation and the optimization of clinical trials in:

 

  • Pharma and Biotech
  • CROs
  • Med Device
  • Research Institutes
  • Regulatory Bodies
Share on Twitter
Share on LinkedIn

Get started with nQuery today

Try for free and upgrade as your team grows